Industry Insight | Variant Bio Launches AI-Powered Platform to Accelerate Drug Discovery Using Genetic Data
January 6, 2026 — Boston — Biotech company Variant Bio announced on Tuesday the launch of a new artificial intelligence-driven platform designed to accelerate the discovery and development of new dr...
More+
Industry Insight | Johnson & Johnson Reaches Drug Pricing Deal with U.S. Government
Johnson & Johnson has reached an agreement with the U.S. government to lower prices on select prescription drugs, marking a significant development in ongoing negotiations between the pharmaceutic...
More+
Industry Insight | NKGen Biotech's SNK02 Cellular Therapy Granted FDA Fast Track Designation for Refractory Solid Tumors
SANTA ANA, Calif., Jan. 10, 2026 – NKGen Biotech, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for...
More+
Industry Insight | FDA Expands Regulatory Flexibility for Cell and Gene Therapy Development
January 2026The U.S. Food and Drug Administration (FDA) has announced an updated regulatory approach aimed at increasing flexibility in the development and manufacturing oversight of cell and gene the...
More+
Industry Insight | FDA Declines Approval of Atara’s Cell Therapy for Rare Blood Cancer
January 13, 2026The U.S. Food and Drug Administration (FDA) has declined to approve Atara Biotherapeutics’ cell therapy tabelecleucel for the treatment of Epstein-Barr virus positive post-transplant ...
More+
Industry Insight | Asia-Pacific Gene Therapy Market Poised to Reach US$14.59 Billion by 2033, Report Says
January 2026 — Industry NewsThe Asia-Pacific gene therapy market is projected to experience rapid growth over the next decade, with market size expected to reach approximately US$14.59 billion by 20...
More+
Industry Insight | Groundbreaking Phase III Cell Therapy Trial for Parkinson’s Disease Begins Across Australia and North America
January 2026A pivotal Phase III cell therapy clinical trial evaluating a novel donor-derived dopamine-producing cell therapy has commenced enrollment across multiple countries, including Australia, Ca...
More+